mRNA therapy revives p53 to combat ovarian tumors

Ovarian cancer is often very aggressive and responds poorly to the therapies currently available. A recent study by Goethe University Frankfurt and University Hospital Frankfurt offers hope that this could change in the medium term.

Morning Rounds: 3D-printed organs, antimicrobial resistance in Ukraine, and other major health stories of the day

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Institutions push back on scientific misconduct

December 8, 2023

Verily Appoints Myoung Cha as Chief Product Officer

Myoung Cha, Chief Product Officer at Verily What You Should Know: – Verily, an Alphabet precision health technology company appoints Myoung Cha as Chief Product Officer.

February 8, 2024

FDA Panel Endorses mAb to Prevent RSV in Infants

An FDA advisory committee on Thursday gave strong backing to a monoclonal antibody against respiratory syncytial virus (RSV) to prevent lower respiratory tract disease (LRTD)

June 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.